12-Panel Drug Test
The 12-Panel Drug Test offers the most comprehensive screening, adding MDMA (Ecstasy) and oxycodone to the substances tested. MDMA is commonly used recreationally as Ecstasy, while oxycodone is an opioid pain medication often misused. The 12-Panel Test covers marijuana (THC), cocaine, opiates, amphetamines, phencyclidine (PCP), benzodiazepines, barbiturates, methadone, propoxyphene, methaqualone, MDMA, and oxycodone.
Thorough Screening for Enhanced Drug Detection
The 12-Panel Drug Test includes detection for MDMA (Ecstasy) and oxycodone, two commonly abused substances in both recreational and medical contexts.
This test screens for a wide range of both illicit and prescription drugs, making it ideal for environments where both types of substances may be misused.
The 12-Panel Drug Test is ideal for monitoring prescription drug abuse, including substances like oxycodone, providing a detailed understanding of a person’s substance use.
Used in legal investigations and healthcare settings, the 12-Panel Test ensures that individuals are screened for a broad spectrum of substances, helping to address substance abuse issues.
This test is used by employers who prioritize a drug-free workplace. By screening for 12 different substances, it ensures employees are not under the influence of drugs that could affect their work performance.